Cytokine adsorption and ECMO in patients with COVID-19 - Author's reply
- PMID: 34242580
- PMCID: PMC8260101
- DOI: 10.1016/S2213-2600(21)00274-5
Cytokine adsorption and ECMO in patients with COVID-19 - Author's reply
Conflict of interest statement
AS reports research grants and lecture fees from CytoSorbents and lecture fees from Abiomed, unrelated to this Correspondence.
Comment on
-
Cytokine adsorption in patients with severe COVID-19 pneumonia requiring extracorporeal membrane oxygenation (CYCOV): a single centre, open-label, randomised, controlled trial.Lancet Respir Med. 2021 Jul;9(7):755-762. doi: 10.1016/S2213-2600(21)00177-6. Epub 2021 May 14. Lancet Respir Med. 2021. PMID: 34000236 Free PMC article. Clinical Trial.
-
Cytokine adsorption and ECMO in patients with COVID-19.Lancet Respir Med. 2021 Aug;9(8):e69-e70. doi: 10.1016/S2213-2600(21)00276-9. Epub 2021 Jul 6. Lancet Respir Med. 2021. PMID: 34242579 Free PMC article. No abstract available.
-
Cytokine adsorption and ECMO in patients with COVID-19.Lancet Respir Med. 2021 Aug;9(8):e71. doi: 10.1016/S2213-2600(21)00285-X. Epub 2021 Jul 6. Lancet Respir Med. 2021. PMID: 34242581 Free PMC article. No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
